The RyR2-G4663S mutation, which is at the corresponding residue as the RyR1-G4733E, was reported to be associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) (14). This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.